Consumer demand for GLP-1 drugs like Ozempic and Wegovy has drawn a flood of new entrants. Yaccarino will have to find a way ...

Though Yaccarino does not have experience in health tech, eMed said in a press release that they sought her out for her ...

Yaccarino has been named CEO of Miami-based eMed Population Health, which calls itself “the leading digital health platform ...

The eMed Population Health digital health platform announced Tuesday that former X Chief Executive Officer Linda Yaccarino ...

Yaccarino will be CEO of a unit at the company, which focuses on patients taking weight-management and diabetes medications.

Digital health platform eMed Population Health said on Tuesday it has appointed Linda Yaccarino, the former CEO of social ...

Former X CEO Linda Yaccarino has been tapped as the new CEO of eMed Population Health, an AI‑driven health tech startup.

EMED Technologies, a global leader in drug delivery and innovative infusion therapy devices, announced the members of its Scientific Advisory Board (SAB). Established in 1991, EMED Technologies is a ...

The choice reflects the company's aims to revolutionize chronic care and expand global health solutions through innovative ...

MIAMI, Aug. 5, 2025 /PRNewswire/ -- eMed Population Health, the leading digital health platform for GLP-1 /GIP population ...

Yaccarino, an advertising industry veteran, exited Elon Musk's X after two turbulent years during which she tried to revive ...